FDA Oncology Announcements

Granulocyte colony-stimulating factor × Clear all

2 Announcements

FDA approves first biosimilar to Neulasta to decrease the risk of infection during cancer treatment

Drugs: Fulphila (pegfilgrastim-jmdb) · Granulocyte colony-stimulating factor, Neulasta (pegfilgrastim) · Granulocyte colony-stimulating factor

Filgrastim-sndz

Drug: ZARXIO (filgrastim-sndz) · Granulocyte colony-stimulating factor